Robert Silva
About Robert Silva
Robert Silva is the Area Vice President at Komodo Health and Director of Client Services, Market Access at EVERSANA, with extensive experience in pharmaceutical marketing, training, and market access.
Company
Robert Silva currently holds significant positions at two organizations: Komodo Health and EVERSANA. At Komodo Health, he serves as Area Vice President, overseeing operations in the United States. In parallel, he acts as the Director of Client Services, Market Access at EVERSANA. His dual roles highlight his extensive experience and expertise in the healthcare industry.
Title
Robert Silva serves as Area Vice President at Komodo Health and Director of Client Services, Market Access at EVERSANA. His roles involve significant responsibilities and intricate knowledge of pharmaceutical marketing and client services.
Education and Expertise
Robert Silva holds a Bachelor's Degree in Economics from both Rutgers Business School and the City University of New York-College of Staten Island. He possesses specialized skills in Pharmacology and Physiology, alongside a deep understanding of Health Economics and Outcomes Research (HEOR) and Budget Impact Models. His educational background is complemented by his extensive experience in project management and Salesforce.
Background
Robert Silva has a comprehensive background in the pharmaceutical and healthcare sectors. His prior roles include stints as Key Account Manager at Decision Resources Group for four years and Primary Care Sales Representative at Boehringer Ingelheim for five years in New Jersey. He also worked as an Independent Broker at Med Mal Associates, LLC, and a Health Care Accounts Manager at Procter and Gamble for 13 years. Additionally, he has experience in various managerial roles at Enterprise Rent A Car and Lake Business Products.
Skills and Experience
Robert Silva is adept in several key areas essential to pharmaceutical marketing and healthcare services. He possesses expertise in contracting and working with medical and prescription claims data. His skill set includes custom research and insights, along with a background in developing ICER reviews. Additionally, he has worked extensively with syndicated research and formulary insights, including restrictions details and insights such as PA, ST, and QL.